We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002281:SZSEAccelink Technologies Co,Ltd. Analysis

Data as of 2026-03-17 - not real-time

CN¥79.28

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Accelink Technologies is trading at CNY 79.28, comfortably above its 20‑day (≈78.85) and 50‑day (≈74.40) simple moving averages, with the 200‑day SMA (≈61.01) far below, indicating a strong bullish backdrop. The MACD histogram is positive (≈0.41) and the signal line is bullish, while RSI sits around 50, suggesting momentum remains intact and volume is on an increasing trend. Support sits near 69.75 and resistance near 100.64, giving the stock room to run higher if buying pressure sustains.
Fundamentally, the company posted a 45% revenue surge and maintains healthy operating margins (~20%), but its valuation is stretched: a trailing P/E of 67.8 far exceeds the industry average of 34.2 and the DCF‑derived fair value of ≈65.2, implying a negative upside of about 11%. Dividend yield is modest at 0.31% with a 22% payout, yet strong cash generation (free cash flow ≈1.31 B CNY) and low net debt support sustainability. However, volatility is high (≈70% 30‑day) and while beta is low (~0.18), regulatory and geographic exposure to China add layers of risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (price above SMAs, MACD bullish)
  • Overvalued relative to DCF and peer P/E
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth (45%) and solid cash flow
  • Elevated valuation multiples remain a drag
  • Regulatory environment for Chinese tech firms

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained earnings growth and expanding market for optical communication
  • Robust balance sheet with ample cash and low net debt
  • Industry tailwinds in data‑center and 5G infrastructure

Key Metrics & Analysis

Financial Health

Revenue Growth45.00%
Profit Margin8.02%
P/E Ratio67.8
ROE9.61%
ROA4.54%
Debt/Equity4.33
P/B Ratio6.5
Op. Cash FlowCN¥1.4B
Free Cash FlowCN¥1.3B
Industry P/E34.2

Technical Analysis

TrendBullish
RSI50.6
SupportCN¥69.75
ResistanceCN¥100.64
MA 20CN¥78.85
MA 50CN¥74.40
MA 200CN¥61.01
MACDBullish
VolumeIncreasing
Fear & Greed Index79.64

Valuation

Fair ValueCN¥65.22
Target PriceCN¥70.24
Upside/Downside-11.41%
GradeOvervalued
TypeGrowth
Dividend Yield0.31%

Risk Assessment

Beta0.18
Volatility69.63%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.